Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?
Hypertension
.
2018 Aug;72(2):291-293.
doi: 10.1161/HYPERTENSIONAHA.118.11455.
Epub 2018 Jul 2.
Authors
Sverre E Kjeldsen
1
2
,
Ingrid Os
3
4
,
Peter M Nilsson
5
Affiliations
1
From the Institute for Clinical Medicine, University of Oslo, Norway (S.E.K., I.O.) s.e.kjeldsen@medisin.uio.no.
2
Department of Cardiology (S.E.K.).
3
From the Institute for Clinical Medicine, University of Oslo, Norway (S.E.K., I.O.).
4
Department of Nephrology (I.O.).
5
Oslo University Hospital Ullevål, Norway; and Department of Clinical Sciences, Skåne University Hospital, Lund University, Malmö, Sweden (P.M.N.).
PMID:
29967041
DOI:
10.1161/HYPERTENSIONAHA.118.11455
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antihypertensive Agents
Blood Glucose
Blood Pressure / drug effects
Diabetes Mellitus, Type 2*
Humans
Substances
Antihypertensive Agents
Blood Glucose